These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16540172)

  • 1. Sphingomyelinases D induce direct association of C1q to the erythrocyte membrane causing complement mediated autologous haemolysis.
    Tambourgi DV; Pedrosa MF; de Andrade RM; Billington SJ; Griffiths M; van den Berg CW
    Mol Immunol; 2007 Jan; 44(4):576-82. PubMed ID: 16540172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.
    Tambourgi DV; De Sousa Da Silva M; Billington SJ; Gonçalves De Andrade RM; Magnoli FC; Songer JG; Van Den Berg CW
    Immunology; 2002 Sep; 107(1):93-101. PubMed ID: 12225367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis.
    Tambourgi DV; Magnoli FC; van den Berg CW; Morgan BP; de Araujo PS; Alves EW; Da Silva WD
    Biochem Biophys Res Commun; 1998 Oct; 251(1):366-73. PubMed ID: 9790962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
    Tambourgi DV; Magnoli FC; Von Eickstedt VR; Benedetti ZC; Petricevich VL; da Silva WD
    J Immunol; 1995 Nov; 155(9):4459-66. PubMed ID: 7594608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom.
    de Andrade SA; Murakami MT; Cavalcante DP; Arni RK; Tambourgi DV
    Toxicon; 2006 Mar; 47(4):380-6. PubMed ID: 16458340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR; Hwang HY; Boackle RJ
    Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation.
    Lopes PH; Bertani R; Gonçalves-de-Andrade RM; Nagahama RH; van den Berg CW; Tambourgi DV
    PLoS Negl Trop Dis; 2013; 7(8):e2394. PubMed ID: 23991242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes of Loxosceles venom sphingomyelinases monitored by circular dichroism.
    de Andrade SA; Pedrosa MF; de Andrade RM; Oliva ML; van den Berg CW; Tambourgi DV
    Biochem Biophys Res Commun; 2005 Feb; 327(1):117-23. PubMed ID: 15629438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
    J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
    Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
    Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis.
    Tambourgi DV; Morgan BP; de Andrade RM; Magnoli FC; van Den Berg CW
    Blood; 2000 Jan; 95(2):683-91. PubMed ID: 10627480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S; Gewurz H; Mold C
    J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.
    Lopes PH; Murakami MT; Portaro FCV; Mesquita Pasqualoto KF; van den Berg C; Tambourgi DV
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):310-321. PubMed ID: 30734604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
    Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis.
    de Santi Ferrara GI; Fernandes-Pedrosa Mde F; Junqueira-de-Azevedo Ide L; Gonçalves-de-Andrade RM; Portaro FC; Manzoni-de-Almeida D; Murakami MT; Arni RK; van den Berg CW; Ho PL; Tambourgi DV
    Toxicon; 2009 Jun; 53(7-8):743-53. PubMed ID: 19249326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom.
    Chaves-Moreira D; Chaim OM; Sade YB; Paludo KS; Gremski LH; Donatti L; de Moura J; Mangili OC; Gremski W; da Silveira RB; Senff-Ribeiro A; Veiga SS
    J Cell Biochem; 2009 Jul; 107(4):655-66. PubMed ID: 19455508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.